Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metyrapone in Endogenous Cushing's Syndrome
NCT02297945Phase 3Completed
- Sponsor
- HRA Pharma
- Start
- Apr 2015
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of metyrapone in Cushing's syndrome, sponsored by HRA Pharma. Started Apr 2015; status: completed.
02
Drugs
metyrapone
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT02297945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297945.